Ameritas Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-867
| Closed | -$4.54K | – | 3270 |
|
2024
Q1 | $4.54K | Hold |
867
| – | – | ﹤0.01% | 2961 |
|
2023
Q4 | $4.53K | Hold |
867
| – | – | ﹤0.01% | 2984 |
|
2023
Q3 | $13.7K | Hold |
867
| – | – | ﹤0.01% | 2701 |
|
2023
Q2 | $16.9K | Hold |
867
| – | – | ﹤0.01% | 2646 |
|
2023
Q1 | $24.6K | Hold |
867
| – | – | ﹤0.01% | 2385 |
|
2022
Q4 | $29.2K | Hold |
867
| – | – | ﹤0.01% | 2380 |
|
2022
Q3 | $22K | Hold |
867
| – | – | ﹤0.01% | 2492 |
|
2022
Q2 | $38K | Hold |
867
| – | – | ﹤0.01% | 2176 |
|
2022
Q1 | $43K | Hold |
867
| – | – | ﹤0.01% | 2148 |
|
2021
Q4 | $44K | Hold |
867
| – | – | ﹤0.01% | 2206 |
|
2021
Q3 | $48K | Hold |
867
| – | – | ﹤0.01% | 2189 |
|
2021
Q2 | $37K | Hold |
867
| – | – | ﹤0.01% | 2391 |
|
2021
Q1 | $36K | Hold |
867
| – | – | ﹤0.01% | 2282 |
|
2020
Q4 | $40K | Hold |
867
| – | – | ﹤0.01% | 2116 |
|
2020
Q3 | $37K | Hold |
867
| – | – | ﹤0.01% | 2030 |
|
2020
Q2 | $42K | Hold |
867
| – | – | ﹤0.01% | 1943 |
|
2020
Q1 | $40K | Hold |
867
| – | – | ﹤0.01% | 1792 |
|
2019
Q4 | $52K | Hold |
867
| – | – | ﹤0.01% | 1900 |
|
2019
Q3 | $49K | Hold |
867
| – | – | ﹤0.01% | 1890 |
|
2019
Q2 | $48K | Hold |
867
| – | – | ﹤0.01% | 1939 |
|
2019
Q1 | $44K | Hold |
867
| – | – | ﹤0.01% | 1960 |
|
2018
Q4 | $35K | Hold |
867
| – | – | ﹤0.01% | 2019 |
|
2018
Q3 | $60K | Hold |
867
| – | – | ﹤0.01% | 1890 |
|
2018
Q2 | $66K | Buy |
867
+120
| +16% | +$9.14K | ﹤0.01% | 1818 |
|
2018
Q1 | $39K | Hold |
747
| – | – | ﹤0.01% | 2058 |
|
2017
Q4 | $40K | Hold |
747
| – | – | ﹤0.01% | 2052 |
|
2017
Q3 | $40K | Hold |
747
| – | – | ﹤0.01% | 2030 |
|
2017
Q2 | $59K | Buy |
747
+85
| +13% | +$6.71K | ﹤0.01% | 1799 |
|
2017
Q1 | $55K | Buy |
+662
| New | +$55K | ﹤0.01% | 1781 |
|